NVIDIA
NVDA
Tesla
TSLA
Disney
DIS
Apple
AAPL
Netflix
NFLX
US Stock MarketDetailed Quotes
INGN Inogen
- 8.330
- +0.380+4.78%
Close Feb 28 16:00 ET
- 8.330
- 0.0000.00%
Post 16:16 ET
220.99MMarket Cap-5.48P/E (TTM)
8.560High7.940Low408.85KVolume7.950Open7.950Pre Close3.38MTurnover1.89%Turnover RatioLossP/E (Static)26.53MShares13.33052wk High1.27P/B180.23MFloat Cap6.14052wk Low--Dividend TTM21.64MShs Float287.790Historical High--Div YieldTTM7.80%Amplitude4.130Historical Low8.264Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Inogen Stock Forum
Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell
Sunday, 26th January at 12:00 pm
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it has entered into a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ, "Yuwell"), a global home healthcare medical device manufacturer...
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
Monday, 30th December at 8:30 am
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company's ability to market and meet the various needs of patients with chronic...
Second Quarter 2024 Financial Results
Second quarter total revenue increased 6.1% to $88.8 million from $83.6 million in the second quarter of 2023, primarily driven by higher demand and new customers in international and domestic business-to business sales, partially offset by lower direct-to-consumer sales and rental revenue.
Total gross margin was 48.1% in the second quarter of 2024 versus 40.7% in the comparative period in 2023. The increase was driven primarily by low...
An authorized Inogen dealer I work with said that Inogen G4s and G5s are failing more than half of the time forcing them to return them to Inogen. Inogen sells these devices directly to the public and I have to assume Innogen is not performing the additional testing that the dealer is doing or they would be finding the defective POCs before shipping. The specific defect mentioned is the device not recognizing the battery when AC power is disconnected. I would imagine that if the dealer is telling the truth (I have it in writing) there will be a recall on Inogen devices.
No comment yet